Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.5750
H.R.5750: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014
About This Bill
- This bill was introduced in the 113th Congress
- This bill is primarily about health
- Introduced Nov. 20, 2014
- Latest Major Action Dec. 10, 2014
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
4 (3 Democrats, 1 Republican)
Bill Summary
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to extend by six months the exclusivity period for a drug or biological product approved by the Food and Drug Administration (FDA) when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
Date | Description |
---|---|
Nov. 21, 2014 |
Referred to the Subcommittee on Health.
|
Nov. 20, 2014 |
Referred to the House Committee on Energy and Commerce.
|
Nov. 20, 2014 |
Introduced in the House by Gus Bilirakis (R-Fla.) |